Technosphere Insulin
DrugTechnosphere® Insulin (TI) Inhalation Powder, prandial
NCT Number: NCT00642681
Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Parkwood Hospital, London, Ontario, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Technosphere® Insulin (TI) Inhalation Powder, prandial
Time frame: 4 Hours
Mannkind Corporation
Industry
Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02593032
Cardiovascular Diseases, Diabetes Mellitus
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06186245
Acid-Base Imbalance, Acidosis
Lubbock, Texas, United States
View Trial DetailsNCT07800884
Diabetes Mellitus, Diet Interventions
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT07779044
Behavior, Behavioral Symptoms
Damascus, Damascus Governorate, Syria
View Trial Details